PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
← Leaderboard
HUM
Ticker

HUM

Congressional Trades
74
by 8 members
Buys
38
51%
Sells
36
49%
Total Volume
$2.3M
midpoint
Unique Traders
8
members

Party Breakdown

Democrats30 · 41%
Republicans44 · 59%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthALIGNED

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←
Month
→ Republican
01
Feb '24
12
2
Mar '24
1
Apr '24
4
May '24
3
Aug '24
01
Sep '24
01
03
Oct '24
1
Nov '24
01
Jan '25
2
31
Feb '25
1
11
Mar '25
02
Apr '25
1
12
May '25
32
01
Jun '25
32
1
Jul '25
3
Aug '25
22
Sep '25
2
Oct '25
25
02
Nov '25
01
01
Jan '26
02
Feb '26
03
1
Mar '26
Democrats1416Neutral
vs
Republicans2420Neutral
Net buyingNet selling⚡ Party split

💼 Lobbying Filings

all →
  • 2026-04-20$2.5M
    HUMANA INC
    Medicare Advantage (MA) Policy and Reimbursement Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R. 3514/S.1816, Improving Seniors' Timely Access to Care Act of 2025 (119th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final Rule (CMS 1793-F) Implementation of CMS Interoperability and Prior Authorization final rule (CMS-0057-F) Calendar Year (CY) 2025 Home Health Prospective Payment System Final Rule (CMS-1803-F) Contract Year 2025 Medic
  • 2026-04-20$60K
    HUMANA INC.
    Issues related to the One Big Beautiful Bill Act (PL 119-21). Issues related to health care payment policy, including Medicare Advantage, Medicare Part D, and other payer policy matters, as well as health care clinical services; Issues related to the One Big Beautiful Bill Act (PL 119-21).
  • 2026-04-17$60K
    HUMANA INC.
    General healthcare policy issues, including Medicare Advantage, Medicare Part D and other payer policy matters, and health care clinical services; S.1105: No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act; PL 119-21: One Big Beautiful Bill Act Issued related to PL 119-21: One Big Beautiful Bill Act
  • 2026-04-15$60K
    HUMANA INC.
    Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services.
  • 2026-01-20$800K
    HUMANA INC
    Medicare Advantage (MA) Policy and Reimbursement Enactment of policies in Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R. 3514/S.1816, Improving Seniors' Timely Access to Care Act of 2025 (119th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Calendar Year (CY) 2024 Home Health Prospective Payment System Final Rule (CMS-1780-F) Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final
  • 2026-01-18$40K
    HUMANA INC.
    Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services.
  • 2026-01-17$60K
    HUMANA INC.
    Issues related to health care payment policy, including Medicare Advantage, Medicare Part D, and other payer policy matters, as well as health care clinical services; Issues related to the One Big Beautiful Bill Act (PL 119-21). Issues related to the One Big Beautiful Bill Act (PL 119-21).
  • 2026-01-16$60K
    HUMANA INC.
    General healthcare policy issues, including Medicare Advantage, Medicare Part D and other payer policy matters, and health care clinical services; S.1105: No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act; PL 119-21: One Big Beautiful Bill Act Issued related to PL 119-21: One Big Beautiful Bill Act
  • 2025-10-20$490K
    HUMANA INC
    Medicare Advantage (MA) Policy and Reimbursement Enactment of policies in Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies Medicare Part D Issues Medicaid Policy Issues Including Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 H.R. 3514/S.1816, Improving Seniors' Timely Access to Care Act of 2025 (119th Congress) Prior Authorization Policy and Regulatory Issues CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health Calendar Year (CY) 2024 Home Health Prospective Payment System Final Rule (CMS-1780-F) Hospital Outpatient Prospective Payment System (OPPS): Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Final
  • 2025-10-20$60K
    HUMANA INC.
    General healthcare policy issues, including Medicare Advantage, Medicare Part D and other payer policy matters, and health care clinical services; S.1105: No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act; PL 119-21: One Big Beautiful Bill Act Issued related to PL 119-21: One Big Beautiful Bill Act

Congressional Momentum

buy vs. sell pressureDISTRIBUTING

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
7
1 buy6 total5 sells
$8K buys · $107K sells
All-Time
60
38 buys74 total36 sells
$1.4M buys · $931K sells
Cumulative Net Position (buy vol − sell vol)
+$439K
2024-0274 trades plotted2026-03

Trade Activity Timeline

Congressional buys & sells by month · last 22 months w/ activity

24/02
24/03
24/04
24/05
24/08
24/09
24/10
24/11
25/01
25/02
25/03
25/04
25/05
25/06
25/07
25/08
25/09
25/10
25/11
26/01
26/02
26/03
BuysSellsOtherHigh-volume month

Who Moved First

each row = one member · sorted by earliest disclosed trade
6 buyers ·8 sellers
20252026DRo Khanna20×2024-02-13 · sell · $8K2024-03-20 · buy · $8K2024-03-25 · buy · $8K2024-04-26 · buy · $8K2024-10-02 · sell · $8K2024-10-11 · sell · $8K2024-10-14 · sell · $8K2024-11-15 · buy · $8K2025-02-19 · sell · $8K2025-02-25 · buy · $8K2025-03-06 · buy · $8K2025-03-12 · sell · $8K2025-05-19 · buy · $8K2025-06-23 · sell · $8K2025-07-25 · buy · $8K2025-08-04 · buy · $8K2026-01-29 · sell · $8K2026-02-17 · sell · $8K2026-02-24 · sell · $8K2026-03-23 · buy · $8KRMichael McCaul24×2024-02-21 · buy · $175K2024-04-10 · buy · $33K2024-04-19 · buy · $33K2024-04-24 · buy · $33K2024-04-29 · buy · $33K2024-05-02 · buy · $33K2024-05-14 · buy · $75K2024-05-22 · buy · $75K2024-08-26 · sell · $75K2024-11-19 · sell · $75K2025-01-15 · buy · $33K2025-01-23 · buy · $175K2025-04-10 · buy · $175K2025-05-19 · buy · $33K2025-05-19 · buy · $75K2025-05-28 · buy · $33K2025-06-16 · sell · $75K2025-06-20 · buy · $175K2025-06-27 · sell · $175K2025-08-21 · sell · $33K2025-08-22 · sell · $75K2025-10-27 · sell · $33K2025-11-04 · sell · $33K2026-02-17 · sell · $75KRByron Donalds2×2024-02-22 · sell · $75K2024-02-22 · sell · $8KRJohn James1×2024-09-04 · sell · $8KRRobert Bresnahan3×2025-02-25 · buy · $8K2025-05-15 · sell · $8K2025-05-15 · sell · $8KDGilbert Cisneros10×2025-02-26 · buy · $8K2025-02-26 · buy · $8K2025-04-29 · sell · $8K2025-04-29 · sell · $8K2025-05-30 · sell · $8K2025-05-30 · sell · $8K2025-08-05 · buy · $8K2025-08-05 · buy · $8K2025-11-12 · sell · $8K2025-11-12 · sell · $8KRLisa McClain10×2025-06-24 · buy · $8K2025-06-24 · buy · $8K2025-09-25 · buy · $8K2025-09-25 · buy · $8K2025-10-30 · sell · $8K2025-10-30 · buy · $8K2025-10-30 · sell · $8K2025-10-30 · buy · $8K2025-10-31 · sell · $8K2025-10-31 · sell · $8KRJulia Letlow4×2025-08-08 · buy · $8K2025-08-08 · buy · $8K2026-02-10 · sell · $8K2026-02-10 · sell · $8K
BuySellOtherDot size ∝ trade size · top 8 most-active traders shown

All Disclosed Trades

DateMemberActionAmountFiling Delay
2026-03-23DRo KhannaBUY$1K – $15K15d
2026-02-10RJulia LetlowSELL$1K – $15K31d
2026-02-10RJulia LetlowSELL$1K – $15K30d
2026-02-17RMichael McCaulSELL$50K – $100K21d
2026-02-17DRo KhannaSELL$1K – $15K20d
2026-02-24DRo KhannaSELL$1K – $15K13d
2026-01-29DRo KhannaSELL$1K – $15K8d
2025-08-08RJulia LetlowBUY$1K – $15K159d
2025-08-08RJulia LetlowBUY$1K – $15K158d
2025-11-12DGilbert CisnerosSELL$1K – $15K34d
2025-11-12DGilbert CisnerosSELL$1K – $15K33d
2025-11-04RMichael McCaulSELL$15K – $50K35d
2025-10-31RLisa McClainSELL$1K – $15K24d
2025-10-30RLisa McClainSELL$1K – $15K25d
2025-10-30RLisa McClainBUY$1K – $15K25d
2025-10-31RLisa McClainSELL$1K – $15K21d
2025-10-30RLisa McClainSELL$1K – $15K22d
2025-10-30RLisa McClainBUY$1K – $15K22d
2025-10-27RMichael McCaulSELL$15K – $50K14d
2025-09-25RLisa McClainBUY$1K – $15K28d
2025-09-25RLisa McClainBUY$1K – $15K27d
2025-08-05DGilbert CisnerosBUY$1K – $15K41d
2025-08-05DGilbert CisnerosBUY$1K – $15K38d
2025-08-22RMichael McCaulSELL$50K – $100K20d
2025-08-21RMichael McCaulSELL$15K – $50K21d
2025-08-04DRo KhannaBUY$1K – $15K36d
2025-06-24RLisa McClainBUY$1K – $15K51d
2025-06-24RLisa McClainBUY$1K – $15K50d
2025-07-25DRo KhannaBUY$1K – $15K13d
2025-06-23DRo KhannaSELL$1K – $15K16d
2025-06-27RMichael McCaulSELL$100K – $250K10d
2025-06-20RMichael McCaulBUY$100K – $250K17d
2025-06-16RMichael McCaulSELL$50K – $100K21d
2025-05-15RRobert BresnahanSELL$1K – $15K26d
2025-05-19DRo KhannaBUY$1K – $15K22d
2025-05-30DGilbert CisnerosSELL$1K – $15K10d
2025-05-28RMichael McCaulBUY$15K – $50K12d
2025-05-19RMichael McCaulBUY$15K – $50K21d
2025-05-19RMichael McCaulBUY$50K – $100K21d
2025-05-15RRobert BresnahanSELL$1K – $15K25d
2025-05-30DGilbert CisnerosSELL$1K – $15K7d
2025-04-10RMichael McCaulBUY$100K – $250K32d
2025-04-29DGilbert CisnerosSELL$1K – $15K8d
2025-04-29DGilbert CisnerosSELL$1K – $15K7d
2025-03-12DRo KhannaSELL$1K – $15K29d
2025-03-06DRo KhannaBUY$1K – $15K35d
2025-02-25RRobert BresnahanBUY$1K – $15K30d
2025-02-26DGilbert CisnerosBUY$1K – $15K8d
2025-02-25DRo KhannaBUY$1K – $15K9d
2025-02-19DRo KhannaSELL$1K – $15K15d
2025-02-26DGilbert CisnerosBUY$1K – $15K6d
2025-01-23RMichael McCaulBUY$100K – $250K19d
2025-01-15RMichael McCaulBUY$15K – $50K27d
2024-11-19RMichael McCaulSELL$50K – $100K27d
2024-11-15DRo KhannaBUY$1K – $15K20d
2024-10-14DRo KhannaSELL$1K – $15K25d
2024-10-11DRo KhannaSELL$1K – $15K28d
2024-10-02DRo KhannaSELL$1K – $15K37d
2024-02-22RByron DonaldsSELL$50K – $100K260d
2024-02-22RByron DonaldsSELL$1K – $15K260d
2024-08-26RMichael McCaulSELL$50K – $100K21d
2024-09-04RJohn JamesSELL$1K – $15K2d
2024-05-22RMichael McCaulBUY$50K – $100K22d
2024-05-14RMichael McCaulBUY$50K – $100K30d
2024-05-02RMichael McCaulBUY$15K – $50K42d
2024-04-29RMichael McCaulBUY$15K – $50K12d
2024-04-24RMichael McCaulBUY$15K – $50K17d
2024-04-19RMichael McCaulBUY$15K – $50K22d
2024-04-10RMichael McCaulBUY$15K – $50K31d
2024-04-26DRo KhannaBUY$1K – $15K10d
2024-03-25DRo KhannaBUY$1K – $15K11d
2024-03-20DRo KhannaBUY$1K – $15K16d
2024-02-21RMichael McCaulBUY$100K – $250K23d
2024-02-13DRo KhannaSELL$1K – $15K22d